Fertility-sparing options for patients with gynecologic malignancies

Oncologist

Volumn 10, Issue 8, 2005, Pages 613-622

  Leitao Jr , Mario M ^a   Chi, Dennis S ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cervical cancer; Endometrial Cancer radical vaginal trachelectomy; Fertility sparing; Ovarian cancer; Ovarian transposition

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; PACLITAXEL;

AMENORRHEA; CANCER HORMONE THERAPY; CERCLAGE; CONSERVATIVE TREATMENT; DIAGNOSTIC IMAGING; ENDOMETRIUM CANCER; FEMALE FERTILITY; FEMALE GENITAL TRACT TUMOR; HIGH RISK PATIENT; HUMAN; HYSTERECTOMY; OVARY CANCER; OVARY INSUFFICIENCY; PATIENT CARE; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; SALPINGOOOPHORECTOMY; SIDE EFFECT; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER;

ENDOMETRIAL NEOPLASMS; FEMALE; FERTILITY; GENITAL NEOPLASMS, FEMALE; HUMANS; OVARIAN NEOPLASMS; UTERINE CERVICAL NEOPLASMS;

EID: 26444457335     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.10-8-613     Document Type: Review

References (67)

1. Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Ries LAG, Eisner MP, Kosay CL et al., eds. SEER Cancer Statistics Review, 1975-2001. Bethesda, MD: National Cancer Institute. Available at http://seer.cancer.gov/csr/1975_2001. Accessed December 23, 2004.
3. Berek JS. Ovarian cancer. In: Berek JS, ed. Novak's Gynecology, Thirteenth Edition. Philadelphia: Lippincott Williams & Wilkins, 2002:1246-1321.
4. Mathews TJ, Hamilton BE. Mean age of mother, 1970-2000. Natl Vital Stat Rep 2002;51:1-13.
5. Hamilton BE, Martin JA, Sutton PD. Births: preliminary data for 2003. Natl Vital Stat Rep 2004;53:1-17.
6. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001;7:535-543.
7. McCall ML, Keaty EC, Thompson JD. Conservation of ovarian tissue in the treatment of carcinoma of the cervix with radical surgery. Am J Obstet Gynecol 1958;75:590-600; discussion 600-605.
8. Anderson B, LaPolla J, Turner D et al. Ovarian transposition in cervical cancer. Gynecol Oncol 1993;49:206-214.
9. Morice P, Castaigne D, Haie-Meder C et al. Laparoscopic ovarian transposition for pelvic malignancies: indications and functional outcomes. Fertil Steril 1998;70:956-960.
10. Morice P, Juncker L, Rey A et al. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril 2000;74:743-748.
11. Bisharah M, Tulandi T. Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol 2003;188:367-370.
12. Tulandi T, Al-Took S. Laparoscopic ovarian suspension before irradiation. Fertil Steril 1998;70:381-383.
13. Visvanathan DK, Cutner AS, Cassoni AM et al. A new technique of laparoscopic ovariopexy before irradiation. Fertil Steril 2003;79:1204-1206.
14. Azem F, Yovel I, Wagman I et al. Surrogate pregnancy in a patient who underwent radical hysterectomy and bilateral transposition of ovaries. Fertil Steril 2003;79:1229-1230.
15. Giacalone PL, Laffargue F, Benos P et al. Successful in vitro fertilization-surrogate pregnancy in a patient with ovarian transposition who had undergone chemotherapy and pelvic irradiation. Fertil Steril 2001;76:388-389.
16. Morice P, Thiam-Ba R, Castaigne D et al. Fertility results after ovarian transposition for pelvic malignancies treated by external irradiation or brachytherapy. Hum Reprod 1998;13:660-663.
17. Morice P, Haie-Meder C, Pautier P et al. Ovarian metastasis on transposed ovary in patients treated for squamous cell carcinoma of the uterine cervix: report of two cases and surgical implications. Gynecol Oncol 2001;83:605-607.
18. Sonoda Y, Abu-Rustum NR, Gemignani ML et al. A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible? Gynecol Oncol 2004;95:534-538.
19. Benedet JL, Anderson GH. Stage IA carcinoma of the cervix revisited. Obstet Gynecol 1996;87:1052-1059.
20. Roman LD, Felix JC, Muderspach LI et al. Risk of residual invasive disease in women with microinvasive squamous cancer in a conization specimen. Obstet Gynecol 1997;90:759-764.
21. Ueda M, Ueki K, Kanemura M et al. Conservative excisional laser conization for early invasive cervical cancer. Gynecol Oncol 2004;95:231-234.
22. Dargent D, Brun JL, Roy M et al. The radical trachelectomy: Analternative to radical hysterectomy in the treatment of invasive cancers that develop on the external os of the uterine cerix. J Obstet Gynecol 1994;2:285-292. [French]
23. Roy M, Plante M. Pregnancies after radical vaginal trachelectomy for early-stage cervical cancer. Am J Obstet Gynecol 1998;179:1491-1496.
24. Plante M, Roy M. Radical trachelectomy. In: Gershenson D, Fowler M, eds. Operative Techniques in Gynecologic Surgery. Philadelphia: WB Saunders, 1997:187-199.
25. Covens A, Shaw P, Murphy J et al. Is radical trachelectomy a safe alternative to radical hysterectomy for patients with stage IA-B carcinoma of the cervix? Cancer 1999;86:2273-2279.
26. Shepherd JH, Mould T, Oram DH. Radical trachelectomy in early stage carcinoma of the cervix: outcome as judged by recurrence and fertility rates. B JOG 2001;108:882-885.
27. Burnett AF, Roman LD, O'Meara AT et al. Radical vaginal trachelectomy and pelvic lymphadenectomy for preservation of fertility in early cervical carcinoma. Gynecol Oncol 2003;88:419-423.
28. Schlaerth JB, Spirtos NM, Schlaerth AC. Radical trachelectomy and pelvic lymphadenectomy with uterine preservation in the treatment of cervical cancer. Am J Obstet Gynecol 2003;188:29-34.
29. Mathevet P, Laszlo de Kaszon E, Dargent D. [Fertility preservation in early cervical cancer.] Gynecol Obstet Fertil 2003;31:706-712. French.
30. Plante M, Renaud MC, Francois H et al. Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature. Gynecol Oncol 2004;94:614-623.
31. Bernardini M, Barrett J, Seaward G et al. Pregnancy outcomes in patients after radical trachelectomy. Am J Obstet Gynecol 2003;189:1378-1382.
32. McGee WB. Carcinoma of the endometrium in women under forty years of age: report of three cases. Obstet Gynecol 1958;11:388-390.
33. Crissman JD, Azoury RS, Barnes AE et al. Endometrial carcinoma in women 40 years of age or younger. Obstet Gynecol 1981;6:699-704.
34. Gallup DG, Stock RJ. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol 1984;64:417-420.
35. Quinn MA, Kneale BJ, Fortune DW. Endometrial carcinoma in premenopausal women: a clinicopathological study. Gynecol Oncol 1985;20:298-306.
36. Gitsch G, Hanzal E, Jensen D et al. Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol 1995;85:504-508.
37. Evans-Metcalf ER, Brooks SE, Reale FR et al. Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol 1998;91:349-354.
38. Ostor AG, Adam R, Gutteridge BH et al. Endometrial carcinoma in young women. Aust N Z J Obstet Gynaecol 1982;22:38-42.
39. Farhi DC, Nosanchuk J, Silverberg SG. Endometrial adenocarcinoma in women under 25 years of age. Obstet Gynecol 1986;68:741-745.
40. Moukhtar M, Aleem FA, Hung HC et al. The reversible behavior of locally invasive endometrial carcinoma in a chromosomally mosaic (45,X/46Xr(X)) young woman treated with Clomid®. Cancer 1977;40:2957-2966.
41. Kim YB, Holschneider CH, Ghosh K et al. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer 1997;79:320-327.
42. Tran BN, Connell PP, Waggoner S et al. Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am J Clin Oncol 2000;23:476-480. (CCT)
43. Geisler HE, Huber CP, Rogers S. Carcinoma of the endometrium in premenopausal women. Am J Obstet Gynecol 1969;104:657-663.
44. Barakat RR, Grigsby PW, Sabbatini P et al. Corpus: epithelial tumors. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and Practice of Gynecologic Oncology, Third Edition. Philadelphia: Lippincott-Raven, 2000:919-959.
45. Creasman WT, Morrow CP, Bundy BN et al. Surgical pathologic spread patterns of endometrial cancer: A Gynecologic Oncology Group study. Cancer 1987;60:2035-2041.
46. Stovall TG, Photopulos GJ, Poston WM et al. Pipelle endometrial sampling in patients with known endometrial carcinoma. Obstet Gynecol 1991;77:954-956.
47. Daniel AG, Peters WA 3rd. Accuracy of office and operating room curettage in the grading of endometrial carcinoma. Obstet Gynecol 1988;71:612-614.
48. Larson DM, Johnson KK, Broste SK et al. Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol 1995;86:38-42.
49. Perez-Medina T, Bajo J, Folgueira G et al. Atypical endometrial hyperplasia treatment with progestogens and gonadotropin-releasing hormone analogues: long-term follow-up. Gynecol Oncol 1999;73:299-304.
50. Hricak H, Stern JL, Fisher MR et al. Endometrial carcinoma staging by MR imaging. Radiology 1987;162:297-305.
51. Lien HH, Blomlie V, Trope C et al. Cancer of the endometrium: value of MR imaging in determining depth of invasion into the myometrium. AJR Am J Roentgenol 1991;157:1221-1223.
52. Sironi S, Taccagni G, Garancini P et al. Myometrial invasion by endometrial carcinoma: assessment by MR imaging. AJR Am J Roentgenol 1992;158:565-569.
53. Yamashita Y, Mizutani H, Torashima M et al. Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging. AJR Am J Roentgenol 1993;161:595-599.
54. Kim SH, Kim HD, Song YS et al. Detection of deep myometrial invasion in endometrial carcinoma: comparison of transvaginal ultrasound, CT, and MRI. J Comput Assist Tomogr 1995;19:766-772.
55. Kinkel K, Kaji Y, Yu KK et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 1999;212:711-718.
56. Ramirez PT, Frumovitz M, Bodurka DC et al. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol 2004;95:133-138.
57. Zanetta G, Bonazzi C, Cantu M et al. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol 2001;19:1015-1020.
58. Lim-Tan SK, Cajigas HE, Scully RE. Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases. Obstet Gynecol 1988;72:775-781.
59. Morice P, Camatte S, El Hassan J et al. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril 2001;75:92-96.
60. Zanetta G, Rota S, Chiari S et al. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol 2001;19:2658-2664.
61. Winter WE 3rd, Kucera PR, Rodgers W et al. Surgical staging in patients with ovarian tumors of low malignant potential. Obstet Gynecol 2002;100:671-676.
62. Rao GG, Skinner E, Gehrig PA et al. Surgical staging of ovarian low malignant potential tumors. Obstet Gynecol 2004;104:261-266.
63. Menzin AW, Rubin SC, Noumoff JS et al. The accuracy of a frozen section diagnosis of borderline ovarian malignancy. Gynecol Oncol 1995;59:183-185.
64. Houck K, Nikrui N, Duska L et al. Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis. Obstet Gynecol 2000;95:839-843.
65. Pinto PB, Andrade LA, Derchain SF. Accuracy of intraoperative frozen section diagnosis of ovarian tumors. Gynecol Oncol 2001;81:230-232.
66. Tangjitgamol S, Jesadapatrakul S, Manusirivithaya S et al. Accuracy of frozen section in diagnosis of ovarian mass. Int J Gynecol Cancer 2004;14:212-219.
67. Schilder JM, Thompson AM, DePriest PD et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol 2002;87:1-7.